142 related articles for article (PubMed ID: 185242)
1. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
Russell AS; Kaiser JT
J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
[TBL] [Abstract][Full Text] [Related]
2. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
Shore SL; Melewicz FM; Gordon DS
J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease.
Russell AS; Essery G
Cancer; 1977 Jul; 40(1):42-5. PubMed ID: 195708
[TBL] [Abstract][Full Text] [Related]
4. Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1.
Heron I; Moller-Larsen A; Berg K
Infect Immun; 1977 Apr; 16(1):48-53. PubMed ID: 194839
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
[TBL] [Abstract][Full Text] [Related]
6. Lysis of virus-infected target cells by antibody-dependent cellular cytotoxicity. I. General requirements of the reaction and temporal relationship between lethal hits and cytolysis.
Romano TJ; Shore SL
Cell Immunol; 1977 Apr; 30(1):66-81. PubMed ID: 193647
[No Abstract] [Full Text] [Related]
7. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.
Moller-Larsen A; Heron I; Haahr S
Infect Immun; 1977 Apr; 16(1):43-7. PubMed ID: 194838
[TBL] [Abstract][Full Text] [Related]
8. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
Melewicz FM; Shore SL; Ades EW; Phillips DJ
J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.
Shimizu F; Hanaumi K; Shimizu Y; Kumagai K
Infect Immun; 1977 May; 16(2):531-6. PubMed ID: 193792
[TBL] [Abstract][Full Text] [Related]
10. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
11. Appearanc of cytotoxic cells within the bronchus after local infection with herpes simplex virus.
Clancy R; Rawls WE; Jagannath S
J Immunol; 1977 Sep; 119(3):1102-5. PubMed ID: 197165
[TBL] [Abstract][Full Text] [Related]
12. Direct lymphocytotoxicity against herpes simplex virus infected cells.
Fujimiya Y; Babiuk LA; Rouse BT
Can J Microbiol; 1978 Sep; 24(9):1076-81. PubMed ID: 213180
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
[TBL] [Abstract][Full Text] [Related]
14. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
Subramanian T; Rawls WE
J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
[TBL] [Abstract][Full Text] [Related]
15. T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells.
Pfizenmaier K; Starzinski-Powitz A; Röllinghoff M; Falks D; Wagner H
Nature; 1977 Feb; 265(5595):630-2. PubMed ID: 193023
[No Abstract] [Full Text] [Related]
16. The possible local synthesis of antibodies to herpes simplex virus in normal cerebrospinal fluid.
Russell AS
Can J Neurol Sci; 1976 Nov; 3(4):219-21. PubMed ID: 187307
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.
Haahr S; Rasmussen L; Merigan TC
Infect Immun; 1976 Jul; 14(1):47-54. PubMed ID: 181328
[TBL] [Abstract][Full Text] [Related]
19. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
20. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells: characterization of the effector lymphocyte.
Rola-Pleszczynski M
J Immunol; 1980 Oct; 125(4):1475-80. PubMed ID: 6967905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
